Details of Drug-Metabolizing Enzyme (DME)
Full List of Drug(s) Metabolized by This DME | |||||
---|---|---|---|---|---|
Drugs Approved by FDA | Click to Show/Hide the Full List of Drugs: 9 Drugs | ||||
Diclofenac sodium |
Drug Info | Approved | Osteoarthritis | ICD11: FA00 | [1] |
Dextromethorphan hydrobromide |
Drug Info | Approved | Atherosclerosis | ICD11: BA80 | [2] |
Propranolol hydrochloride |
Drug Info | Approved | Migraine | ICD11: 8A80 | [3] |
Buspirone |
Drug Info | Approved | Anxiety disorder | ICD11: 6B00 | [2], [3] |
Acetaminophen |
Drug Info | Approved | Anaesthesia | ICD11: 8E22 | [2] |
Meclofenamic acid |
Drug Info | Approved | Myalgia | ICD11: FB56 | [4] |
Mefenamic acid |
Drug Info | Approved | Female pelvic pain | ICD11: GA34 | [4] |
Nifedipine |
Drug Info | Approved | Angina pectoris | ICD11: BA40 | [5], [2] |
Chlorzoxazone |
Drug Info | Approved | Anaesthesia | ICD11: 8E22 | [5], [2] |
Drugs in Phase 4 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
Amodiaquine |
Drug Info | Phase 4 | Malaria | ICD11: 1F40 | [2] |
Drugs in Phase 2 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
CCRIS-9277 |
Drug Info | Phase 2 | Posttraumatic stress disorder | ICD11: 6B40 | [2] |
Drugs in Phase 1 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
GEA-6414 |
Drug Info | Phase 1/2 | Parkinsonism | ICD11: 8A00 | [4] |
Preclinical/investigative Agents | Click to Show/Hide the Full List of Drugs: 3 Drugs | ||||
Aniline |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [5], [2] |
Mononitrophenol |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [5], [2] |
Benzyloxyresorufin |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [2] |
Full List of Metabolic Reactions (MR) Catalyzed by This DME | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.